September 2, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Its 6.38% Return on Equity and Market Prospects

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, focusing on the development and commercialization of treatments for central nervous system (CNS) diseases. With a market capitalization..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 6.68% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player in the healthcare sector, carving its niche within the drug manufacturing industry focusing on specialty and generic pharmaceuticals. With a..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring the 8.74% Upside Potential Amidst Innovative Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a compelling player in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With a market capitalization of $1.2 billion, this..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 92% Potential Upside Awaits Investors

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, offering intriguing potential for investors seeking high-growth opportunities in the biotechnology sector. With a market capitalization of..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Healthcare Gem with Robust Revenue Growth and Promising Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the medical instruments and supplies industry, and its recent financial performance underscores its potential as a compelling investment opportunity. With..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a 101% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a pioneering entity in the healthcare sector, has become a focal point of interest for investors seeking exposure to the specialty and generic drug manufacturing..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Potential 41.81% Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology firm specializing in neuroscience, has become a focal point for investors seeking significant growth potential. With its current stock price at $38.71..

Healthcare Services Group, Inc. (HCSG): Investor Outlook and Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a pivotal player in the healthcare sector, offers vital management, administrative, and operational services across the United States. With a focus on housekeeping and..

Evotec SE (EVO): Exploring a 70% Upside Potential in the Drug Discovery Sector

Investors seeking opportunities in the healthcare sector may want to consider Evotec SE (EVO), a leading player in the drug discovery and development industry. With a market capitalization of $1.24..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Investment with Robust Revenue Growth

National HealthCare Corporation (NYSE: NHC) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Murfreesboro, Tennessee, NHC operates a diverse range of..

Indivior PLC (INDV) Stock Analysis: Exploring 20% Upside Potential for Investors

Indivior PLC (INDV), a key player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing, has recently caught the attention of investors due to its..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 109.72% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative RNA medicines platform, PRISM. Based in Singapore, the company is at the forefront of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a Potential 180% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) presents a compelling opportunity for investors in the biotechnology sector, with a potential upside of 180.70% based on the average target price of $45.92. This..

Catalyst Pharmaceuticals (CPRX): Analysts See 66% Upside for This Biotech Innovator

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is catching the attention of investors with its promising potential upside. This commercial-stage biopharmaceutical company, headquartered in Coral Gables, Florida, focuses on developing and commercializing..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 12.21% Potential Upside in the Medical Devices Sector

CONMED Corporation (NYSE: CNMD) stands out in the healthcare sector with its innovative contributions to medical devices, focusing on surgical procedures and orthopedic solutions. With a robust market capitalization of..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a 35% Potential Upside in Healthcare Innovations

Omnicell, Inc. (OMCL), a key player in the healthcare sector, is drawing investor attention with its innovative medication management solutions and a promising potential upside of 35%. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Bold Bet with 262.95% Potential Upside

For investors keen on high-risk, high-reward opportunities, Janux Therapeutics, Inc. (NASDAQ: JANX) might be a compelling consideration. With a staggering potential upside of 262.95%, this clinical-stage biopharmaceutical company is generating..

MiMedx Group, Inc (MDXG) Stock Analysis: Healthcare Innovator with 71.83% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative medical solutions and an enticing potential upside of 71.83%. Headquartered in..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 48% Upside in Synthetic DNA Solutions

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a noteworthy potential upside of 48.31%. With a..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO) is catching the attention of savvy investors looking for opportunities in the healthcare sector. With a current market capitalization of $1.28 billion, this U.S.-based medical devices..

Search

Funds

September 2, 2025

Search

Funds

September 2, 2025

FTSE 100

Funds